12:00 AM
Mar 18, 2002
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

U3 Pharma AG

Martinsried, Germany

Technology: TASC target selection technology

Disease focus: Cancer, non-malignant proliferative diseases


Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >